13G Filing: Foresite Capital Fund III, L.P. and Cymabay Therapeutics Inc. (CBAY)

Page 9 of 11

Page 9 of 11 – SEC Filing

SIGNATURES

After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 6, 2017

FORESITE CAPITAL FUND III, L.P.
By: FORESITE CAPITAL MANAGEMENT III, LLC
Its: General Partner
By: /s/ James Tananbaum
Name: James Tananbaum
Title: Managing Member
FORESITE CAPITAL MANAGEMENT III, LLC
By: /s/ James Tananbaum
Name: James Tananbaum
Title: Managing Member
FORESITE CAPITAL FUND IV, L.P.
By: FORESITE CAPITAL MANAGEMENT IV, LLC
Its: General Partner
By: /s/ James Tananbaum
Name: James Tananbaum
Title: Managing Member
FORESITE CAPITAL MANAGEMENT IV, LLC
By: /s/ James Tananbaum
Name: James Tananbaum
Title: Managing Member
JAMES TANANBAUM
By: /s/ James Tananbaum
Name: James Tananbaum

Follow Cymabay Therapeutics Inc. (NASDAQ:CBAY)

Page 9 of 11